Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Sign in
  • Home
  • Biotech News
  • Conferences
    • Gold Conferences
    • Biotech Conferences
    • Technology Conferences
  • CoronaVirus
    • Precision Vaccinations
  • Internet News
  • Research
  • Reverse Splits
    • Reverse Split News
    • Reverse Split Watch List
    • Reverse Stock Split List
    • Upcoming Reverse Stock Split List
  • More Finance Channels
    • Beverage Stocks
    • Blockchain Stocks
    • Gold Stocks
    • Marijuana Stocks
    • Psychedelic Stocks
    • Stand Down – Wall Street Bears
    • Tiki Hut Fund
Sign in
Welcome!Log into your account
Forgot your password?
Privacy Policy
Password recovery
Recover your password
Search
Tuesday, May 26, 2026
  • Sign in / Join
  • Contact Us
  • Featured News
  • Free Weekly Newsletter
Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.

Internet | Biotech Stock Review

  • Home
  • Biotech News
  • Conferences
    • Gold Conferences
    • Biotech Conferences
    • Technology Conferences
  • CoronaVirus
    • Precision Vaccinations
  • Internet News
  • Research
  • Reverse Splits
    • Reverse Split News
    • Reverse Split Watch List
    • Reverse Stock Split List
    • Upcoming Reverse Stock Split List
  • More Finance Channels
    • Beverage Stocks
    • Blockchain Stocks
    • Gold Stocks
    • Marijuana Stocks
    • Psychedelic Stocks
    • Stand Down – Wall Street Bears
    • Tiki Hut Fund
2024 Watch List

Nine Page Summary Report on GeoVax (GOVX)

Editor / Curator - August 19, 2024
2024 Watch List

GeoVax (GOVX) Provides First Half 2024 Business Update.

Editor / Curator - July 9, 2024
All News

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

Editor / Curator - July 9, 2024
Biotech News

FDA approves Amgen drug for tough-to-treat form of lung cancer.

Editor / Curator - June 19, 2024
2024 Watch List

GeoVax Receives Massive $300+ Million BARDA Project NextGen Award!

Editor / Curator - June 18, 2024
2024 Watch List

GeoVax (GOVX) Research Reports Archive

Editor / Curator - June 18, 2024
2022 Watch List

Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

Editor / Curator - May 14, 2024
2024 Watch List

GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

Editor / Curator - May 13, 2024
2024 Watch List

NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at...

Editor / Curator - May 13, 2024
Biotech News

COVID-19 Immunity From mRNA Booster Does Not Last Very Long.

Editor / Curator - May 10, 2024
1...141516...108Page 15 of 108

Reverse Stock Split, Watch List

Plan Your Day Wisely

May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Apr    

AI Powered Biotech Research Tool

Reverse Stock Split News

Institutional Gold Research

Latest article

Rick Rule Symposium – Conference Cheat Sheet

2026 Watch List Editor / Curator - May 24, 2026
Natural Resource Investing Symposium - Presenter Guide We've attended hundreds and hundreds of Investment Conferences (Barclay, JP Morgan, LD Micro, Piper Sandler, Roth, VRIC) since...

GeoVax (GOVX) Surges 256%, With 207 Million Shares Trading!

2026 Biotech 12 Pack Editor / Curator - May 21, 2026
What an Entertaining Week! ..and it's only Thursday. LIVE QUOTE (MAY 18TH) (MAY 21ST) So Where Does That Leave us Today? Yes, it was a pleasant surprise to see GeoVax...

Americore (AMCOF) Funding Launched. Looks Like Good Entry Point.

2026 Watch List Editor / Curator - May 19, 2026
All Systems Go? A recently completed Magnetometer survey sends a strong signal to investors that the company is advancing its project in a disciplined, data-driven...
Revelers.IO Finance Channel
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
  • Model Portfolio
  • Disclaimer
  • Contact us
  • Write For Us
© Managed by Revelers.IO Media Group Inc.